FrancophonIA/ELRC3.0 huggingface dataset:
English: These frequently asked questions are also available in all EU languages.
Estonian: Käesolevad korduvad küsimused on kättesaadavad kõigi ELi liikmesriikide keeltes.
English: Some content is translated into other official European Union (EU) languages, including public summaries and product information in European public assessment reports (EPARs), question-and-answer documents for the public, information on recruitment, work programmes and summaries of the annual report.
Estonian: Osa sisust on tõlgitud teistesse ametlikesse Euroopa Liidu (EL) keeltesse, sealhulgas Euroopa avalikest hindamisaruannetest (EPAR) pärinevad avalikud kokkuvõtted ja tooteteave, üldsusele suunatud küsimuste-vastuste dokumendid, värbamiste teave, tööprogrammid ja aastaaruannete kokkuvõtted.
English: The European Commission follows the opinion of the Agency in almost all cases.
Estonian: Euroopa Komisjon järgib ravimiameti soovitust pea kõikidel juhtudel.
English: Each EPAR includes a summary for the public
Estonian: Iga dokument sisaldab kokkuvõtet avalikkusele.
English: The search is currently only available in English.
Estonian: Praegu töötab otsing üksnes inglise keeles.
English: The members of the Agency's Management Board and scientific committees, and its experts and staff are not permitted to have financial or other interests in the pharmaceutical industry that could affect their impartiality.
Estonian: Ravimiameti juhatuse ja teaduskomiteede liikmetel, ekspertidel ning töötajatel on keelatud omada farmaatsiatööstuses finants- või muid huve, mis võiksid mõjutada nende erapooletust.
English: How can I get hold of a medicine that is not yet authorised?
Estonian: Kuidas ma saan kätte ravimi, mis ei ole veel müügiluba saanud?
English: Can you recommend a medical specialist for my condition?
Estonian: Kas oskate soovitada meditsiinispetsialisti minu seisundi jaoks?
English: Why can I not find information about a particular medicine on your website?
Estonian: Miks ma ei leia teie veebilehelt konkreetse ravimi kohta teavet?
English: Most of the members of the Agency's six scientific committees are nominated by the Member States or the European Commission.
Estonian: Enamiku ravimiameti kuue teaduskomitee liikmetest on määranud liikmesriigid või Euroopa Komisjon.
English: This is a set of documents that explains the scientific conclusion reached by the Agency's Committees at the end of the evaluation process.
Estonian: See on dokumentide kogum, kus selgitatakse teaduslikke järeldusi, millele hindamisprotsessi lõpuks jõuavad ravimiameti komiteed.
English: The Agency has a role in preparing scientific opinions on the quality, safety and efficacy of herbal medicines, to help harmonise this information across the EU.
Estonian: Ravimiametil on oma osa taimsete ravimite kvaliteedi, ohutuse ja efektiivsuse teaduslike seisukohtade ettevalmistamisel, millega aidatakse vastavat teavet kogu Euroopa Liidus kooskõlastada.
English: • still in development and not yet authorised;
Estonian: • alles arendamisel ja sel puudub veel müügiluba;
English: These spontaneous reports of suspected side effects by healthcare professionals, patients or carers are used to continuously monitor the safety of medicines on the market and to ensure that their benefits continue to outweigh their risks.
Estonian: Tervishoiutöötajate, patsientide või hooldajate edastatud spontaanseid teatisi kõrvaltoimete kahtluse kohta kasutatakse turul olevate ravimite ohutuse pidevaks jälgimiseks ja tagamiseks, et ravimi kasulikkus kaaluks üles riskid.
English: The Agency's Management Board is also made up of representatives of Member States and members nominated by the European Commission.
Estonian: Ka ravimiameti juhatusse kuuluvad liikmesriikide esindajad ja Euroopa Komisjoni poolt nimetatud liikmed.
English: How are the Agency's committee members selected?
Estonian: Kuidas valitakse ravimiameti komiteede liikmeid?
English: Can the Agency recommend academic courses?
Estonian: Kas ravimiamet soovitab akadeemilisi kursuseid?
English: The European Medicines Agency charges pharmaceutical companies fees for the services it provides.
Estonian: Euroopa Ravimiamet võtab farmaatsiaettevõtetelt neile pakutavate teenuste eest tasu.
English: The Agency also publishes a monthly newsletter called 'human medicines highlights', which provides key information on the Agency's recent activities on human medicines.
Estonian: Samuti avaldab ravimiamet iga kuu uudiskirja nimega „Human medicines highlights“, mis annab olulist teavet ravimiameti hiljutise tegevuse kohta inimravimite valdkonnas.
English: My medicine has been evaluated by the Agency but is not available in my country.
Estonian: Ravimiamet on ravimit hinnanud, kuid see ei ole minu riigis kättesaadav.
English: Is the Agency's website available in languages other than English?
Estonian: Kas ravimiameti veebileht on ka teistes keeltes peale inglise keele?
English: If you would like to take part in a clinical trial, you should discuss it with your doctor or nurse, who may be able to refer you for a suitable trial.
Estonian: Kui soovite osaleda kliinilises uuringus, tuleb teil arutada seda oma arsti või meditsiiniõega, kellel võib olla võimalik leida teile sobiv uuring.
English: If appropriate, please give the type of organisation you represent (e.g. patient organisation, pharmaceutical company, etc.)
Estonian: Võimaluse korral märkige organisatsiooni liik, mida te esindate (nt patsientide organisatsioon, ravimifirma jne).
English: No, the Agency is unable to recommend academic courses in regulatory affairs, medicine or any other discipline.
Estonian: Ei. Ravimiametil ei ole võimalik soovitada akadeemilisi kursuseid reguleerivküsimuste, meditsiini ega teistes valdkondades.
English: The Agency is not responsible for patents on medicines: issues regarding patent law are not within the Agency's remit.
Estonian: Ei. Ravimiamet ei vastuta ravimitele antud patentide eest: patendiseadust käsitlevad küsimused ei kuulu ravimiameti töövaldkonda.
English: In the European Union (EU), advertising of prescription-only medicines directly to patients and consumers is forbidden.
Estonian: Euroopa Liidus on keelatud retseptiravimite reklaamimine otse patsientidele ja tarbijatele.
English: Cosmetics are evaluated by authorities in each Member State.
Estonian: Kosmeetikatooteid hindavad igas liikmesriigis ametiasutused.
English: The Agency publishes the rules on these fees, including a list of the fees charged for each type of procedure.
Estonian: Ravimiamet avaldab nende tasude kohta eeskirjad, sealhulgas loetelu teenustasudest, mida nõutakse protseduuride eri liikide eest.
English: No. Advertising of medicines is controlled by medicines regulatory authorities in Member States and other national regulatory bodies, together with self-regulation by the pharmaceutical industry.
Estonian: Ei. Ravimitele tehtavat reklaami kontrollivad liikmesriikide ravimiametid ja muud riiklikud ametivõimud koos farmaatsiatööstuse eneseregulatsiooniga.
English: The Agency has no control over these decisions.
Estonian: Ravimiametil puudub nende otsuste üle kontroll.
English: • cosmetics.
Estonian: • kosmeetikatoodetega.
English: Questions about the evaluation of other substances
Estonian: Muude ainete hindamine
English: Can the Agency fund my work?
Estonian: Kas ravimiametil on võimalik mu tööd rahastada?
English: What type of information is available on a medicine evaluated by the Agency?
Estonian: Mis laadi teave on kättesaadav ravimi kohta, mida ravimiamet on hinnanud?
English: The Agency's main responsibility is the protection and promotion of public and animal health, by carrying out scientific evaluations of medicines for human and veterinary use.
Estonian: Ameti põhiülesanne on inimtervishoius ja veterinaarias kasutatavate ravimite hindamise ja järelevalve abil kaitsta ja edendada inimeste ja loomade tervist.
English: The Agency is also unable to give any financial assistance to patients who are trying to get hold of a medicine.
Estonian: Samuti ei saa ravimiamet abistada rahaliselt patsiente, kes püüavad hankida ravimit.
English: Currently, most of the information on the Agency's website is only available in English.
Estonian: Praegu on enamik ravimiameti kodulehel avaldatud teabest kättesaadav ainult ingliskeelsena.
English: The Agency is also not in a position to provide medical advice or to confirm whether your symptoms are being caused by your medicine.
Estonian: Samuti ei ole ravimiametil võimalik anda meditsiinilist nõu ega kinnitada, kas teie sümptomid tekkisid konkreetse ravimi tõttu.
English: To help us direct your query to the right people within the Agency, please indicate whether you are making your enquiry for personal reasons (e.g. a patient or carer, a student, a researcher, a healthcare professional, etc.) or on behalf of an organisation.
Estonian: Teie küsimuse suunamiseks õigele inimesele ravimiametis märkige palun, kas esitate päringu isiklikust huvist lähtudes (nt olete patsient või hooldaja, üliõpilane, uurija, tervishoiutöötaja jne) või mingi organisatsiooni nimel.
English: • not classified as a medicine but as a medical device or a nutritional supplement, both of which are authorised at national level.
Estonian: • mitte klassifitseeritud ravimi, vaid meditsiinilise seadme või toidulisandina, mis saavad müügiloa riikliku menetlusega.
English: The Agency is not involved in these decisions and does not have any information on pricing or reimbursement arrangements in Member States.
Estonian: Ravimiamet ei osale sellistes otsustes ja tal ei ole mingit teavet hindade ega hüvitiste kohta liikmesriikides.
English: Questions about the Agency's website
Estonian: Küsimused ravimiameti veebilehe kohta
English: Can the Agency give me any advice on my treatment or medical condition?
Estonian: Kas ravimiamet saab anda nõu minu ravi või haigusseisundi kohta?
English: To stay up to date with the latest news, features and publications from the Agency, you can subscribe to our RSS feeds or follow EMA on Twitter.
Estonian: Ravimiameti värskeimate uudiste, artiklite ja väljaannetega kursis olemiseks võite liituda meie RSSvooga või jälgida Euroopa Ravimiametit Twitteris.
English: The European Medicines Agency cannot accept side effect reports directly from patients.
Estonian: Euroopa Ravimiamet ei saa vastu võtta kõrvaltoimete teatisi otse patsientidelt.
English: For the Committee for Advanced Therapies, the Committee (CAT) for Orphan Medicinal Products (COMP) and the Paediatric Committee (PDCO), EMA publishes monthly meeting reports in the week following the committee's plenary meeting.
Estonian: Uudsete ravimite komitee (CAT), harvikravimite komitee (COMP) ja pediaatriakomitee (PDCO) jaoks avaldab ravimiamet igakuiste koosolekute aruanded komitee plenaaristungile järgneval nädalal.
English: In the European Union (EU), there are two ways of getting a marketing authorisation for a medicine: the centralised procedure, via the Agency, which results in a single marketing authorisation valid throughout the EU; national authorisation procedures, where individual EU Member States authorise medicines for use in their own territory.
Estonian: Ei. Euroopa Liidus on ravimile müügiloa saamiseks kaks moodust: tsentraliseeritud menetlus ravimiameti kaudu, millega saadakse üks müügiluba, mis kehtib kogu Euroopa Liidus; riiklikud müügiloa menetlused, millega konkreetne Euroopa Liidu liikmesriik annab oma territooriumil kehtiva ravimi müügiloa.
English: A medicine that is authorised in the EU might not be authorised or marketed in countries outside the EU.
Estonian: Euroopa Liidus müügiloa saanud ravimid ei pruugi saada müügiluba või olla müügil väljaspool Euroopa Liitu.
English: Contact the medicines regulatory authorities in these countries to get more information on the availability of medicines in their territories.
Estonian: Võtke ühendust vastavate riikide ravimiametitega, et saada lisateavet ravimite kättesaadavuse kohta nende territooriumil.
English: No, EMA does not directly fund research.
Estonian: Ei. Ravimiamet ei rahasta otseselt uurimistöid.
English: However, some medicines can be supplied to individual patients under special conditions before they have been authorised.
Estonian: Samas on võimalik varustada üksikpatsiente eriolukorras teatud ravimiga enne selle müügiloa andmist.
English: This means that medicines that have received a central marketing authorisation via the Agency may not be available in all European Union (EU) Member States.
Estonian: See tähendab, et ravimiameti kaudu tsentraalse müügiloa saanud ravimid ei pruugi olla kättesaadavad kõigis Euroopa Liidu liikmesriikides.
English: Medicines cannot be placed on the market without authorisation.
Estonian: Ravimeid ei tohi müügiloata turule viia.
English: The European Patent Office may be able to provide information on a specific patent.
Estonian: Konkreetse patendi kohta võite saada teavet Euroopa Patendiametist.
English: You can do this either by talking to a healthcare professional, or in some cases, you can report the side effects directly to the national competent authority using online patient reporting forms or by telephone.
Estonian: Seda saate teha tervishoiutöötaja kaudu või teavitades mõnel juhul otse riigi ravimiametit patsiendi kõrvaltoimete teatise veebivormi või telefoni teel.
English: How can I get onto a clinical trial?
Estonian: Kuidas saan osaleda kliinilises uuringus?
English: The Agency publishes information about all the medicines it assesses as a European public assessment report (EPAR).
Estonian: Teabe kõikide uuritud ravimite kohta avaldab ravimiamet Euroopa avaliku hindamisaruande kokkuvõttes (EPAR).
English: You may wish to consult the EU Clinical Trials Register for information on authorised clinical trials that are ongoing.
Estonian: Võite tutvuda Euroopa Liidu kliiniliste uuringute registriga, et saada teavet käimasolevate heakskiidetud kliiniliste uuringute kohta.
English: The Agency publishes the names of the actives substance of medicines currently under evaluation but cannot say when the medicines will be approved.
Estonian: Ravimiamet avaldab hindamisel olevate ravimite toimeained, kuid ei tea öelda, millal need ravimid heaks kiidetakse.
English: You can search for a medicine by entering its name under ‘search for medicines' on the website's homepage or in the ‘Find medicine' section, by:
Estonian: Ravimit saate otsida, kui kirjutate veebilehel ravimi nimetuse lahtrisse „Search for medicines“ (Otsi ravimit) või otsite alajaotises „Find medicine“ (Leia ravim)
English: Can you help me to get hold of a medicine?
Estonian: Kas saate mind aidata ravimi hankimisel?
English: Can the Agency tell me when a medicine will be approved?
Estonian: Kas ravimiamet saab öelda, millal antakse ravimi müügiluba?
English: Please note that this is an unofficial acronym.
Estonian: See ei ole ametlik suurtähtlühend.
English: During the evaluation procedure, the Agency publishes information relevant to the evaluation timetable in the agenda and minutes of the meetings of its relevant scientific committees.
Estonian: Hindamisprotsessi käigus avaldab ravimiamet hindamise ajakava ja teaduskomiteede oluliste koosolekute protokollid.
English: • browsing by therapeutic area or type of medicine.
Estonian: • ravivaldkonna või ravimi liigi järgi.
English: Food supplements are evaluated at national level, usually by the authorities that deal with food safety and labelling.
Estonian: Tavaliselt teevad seda ametiasutused, kes tegelevad toidu ohutuse ja märgistusega.
English: These include clinical trials and compassionate-use programmes, which Member Sates regulate.
Estonian: Siia kuuluvad kliinilised uuringud ja erilubade alusel ravimite kasutamise programmid, mida liikmesriigid reguleerivad.
English: How can I keep up to date with the Agency's opinions?
Estonian: Kuidas saan ravimiameti arvamustega kursis püsida?
English: The Agency does not have any commercial interests and does not get involved in the distribution of medicines.
Estonian: Ei. Ravimiametil puuduvad ärihuvid ja ta ei osale ravimite levitamises.
English: Although medicines evaluated by EMA receive an authorisation valid in the whole of the EU, decisions on where a medicine is marketed are made by the company that markets the medicine (the marketing-authorisation holder).
Estonian: Kuigi EMA hinnatud ravimid saavad müügiloa kogu ELis, otsustab ravimit turustav firma (müügiloa hoidja), kus ravimit müüakse.
English: The Agency is not involved in recruiting volunteers for clinical trials.
Estonian: Ravimiamet ei värba vabatahtlikke kliinilistesse uuringutesse.
English: The Agency's old acronym of 'EMEA' should not be used any longer.
Estonian: Ärge kasutage ravimiameti vana suurtähtlühendit EMEA.
English: The Agency does not have up-to-date information on the availability of medicines in Member States.
Estonian: Ei. Ravimiametil ei ole ajakohast teavet ravimite kättesaadavuse kohta liikmesriikides.
English: You can also see information on clinical trials ongoing in Europe in the European Union Clinical Trials Register.
Estonian: Euroopas käimasolevate kliiniliste uuringute kohta leiab teavet ka Euroopa Liidu kliiniliste uuringute registrist.
English: Does the Agency control advertising of medicines?
Estonian: Kas ravimiamet kontrollib ravimireklaami?
English: For the Committee for Medicinal Products for Human Use (CHMP) and the Pharmacovigilance Risk Assessment Committee (PRAC), EMA publishes meeting highlights with evaluation outcomes of major public interest on the Friday following their monthly plenary meetings.
Estonian: Inimravimite komitee (CHMP) ja ravimiohutuse riskihindamise komitee (PRAC) jaoks avaldab ravimiamet avalikku tähelepanu pälvinud ravimeid käsitlevate koosolekute ülevaated koos hindamistulemustega igakuisele plenaaristungile järgneval reedel.
English: No, the Agency is unable to supply pens, mugs or other items branded with the Agency's logo.
Estonian: Ei. Ravimiametil ei ole võimalik varustada teid pastakate, tasside ega muude esemetega, millel on ravimiameti logo.
English: The company producing a medicine can only market it once the medicine has received a marketing authorisation from the European Commission.
Estonian: Ravimi tootja saab ravimit turustada üksnes siis, kui see on saanud Euroopa Komisjonilt müügiloa.
English: • browsing the A-to-Z list of human or veterinary medicines evaluated by the Agency;
Estonian: • ravimiameti hinnatud inim- ja veterinaarravimite tähestikulisest loendist;
English: The Agency requires every patient and consumer organisation that it works with to provide financial statements, including details on donors and their contributions.
Estonian: Ravimiamet nõuab finantsaruannet, sealhulgas annetajate ja annetuste üksikasju, igalt patsientide ja tarbijate organisatsioonilt, kellega ta koostööd teeb.
English: I am experiencing a side effect from a medicine.
Estonian: Mul esinevad ravimi kõrvaltoimed.
English: However, the Agency can be consulted on medical devices that contain medicinal substances.
Estonian: Ravimiametilt võib küsida nõu nende meditsiiniseadmete kohta, mis sisaldavad meditsiinis kasutatavaid aineid.
English: How are cosmetics evaluated?
Estonian: Kuidas hinnatakse kosmeetikatooteid?
English: The Agency takes around a year to evaluate a medicine, at the end of which it issues a recommendation on whether the medicine should be approved.
Estonian: Ravimi hindamine võtab aega umbes üks aasta ning hindamisprotsessi lõpus avaldab ravimiamet soovituse, kas ravim peaks müügiloa saama või ei.
English: • the availability of medicines;
Estonian: • ravimite kättesaadavusega;
English: Following a positive recommendation from the Agency, the European Commission takes around two months to approve a medicine.
Estonian: Pärast ravimiametilt positiivse soovituse saamist annab Euroopa Komisjon ligikaudu kahe kuu pärast ravimi müügiloa.
English: To find out if a medicine is currently available in your country through a compassionate-use programme, check with your national medicines regulatory authority or the company responsible for the medicine.
Estonian: Kui soovite teada, kas ravim on teie riigis kättesaadav erilubade alusel ravimite kasutamise programmi kaudu, küsige teavet riigi ravimiametilt või ettevõttelt, kes vastutab konkreetse ravimi eest.
English: Can the Agency provide me with information on patents on medicines?
Estonian: Kas ravimiamet saab anda teavet ravimite patentide kohta?
English: Medical devices are evaluated by the medicines regulatory authorities in each Member State.
Estonian: Meditsiiniseadmeid hindavad iga liikmesriigi ravimiametid.
English: The Agency suggests that you discuss these issues with a healthcare professional, such as your doctor or pharmacist.
Estonian: Ravimiamet soovitab arutada neid küsimusi tervishoiutöötajaga, näiteks arsti või apteekriga.
English: The outcome of the Agency's evaluation is used by the European Commission to decide whether a medicine can be authorised for marketing in the European Union (EU).
Estonian: Ravimiameti antud hinnangut kasutab Euroopa Komisjon, et otsustada, kas anda ravimile Euroopa Liidus müügiluba.
English: The Agency cannot advise individual patients on their treatment or condition.
Estonian: Ei. Ravimiamet ei saa nõustada konkreetseid patsiente nende ravi või seisundi osas.
English: The Agency's responsibilities are limited to the evaluation of medicines for authorisation purposes and their supervision once they are authorised.
Estonian: Ravimiameti vastutusala piirdub ravimite hindamisega müügiloa taotlemisel ja järelevalvega pärast müügiloa andmist.
English: The Agency publishes information on the medicines it evaluates at the time it makes a recommendation as well as after the European Commission has issued a marketing authorisation.
Estonian: Ravimiamet avaldab hinnatavate ravimite kohta teavet samal ajal, kui ta esitab ravimi kohta soovituse, aga ka pärast seda, kui Euroopa Komisjon on ravimi müügiloa andnud.
English: Questions about medical advice
Estonian: Meditsiinilised nõuanded
English: Questions about clinical trials
Estonian: Kliinilised uuringud
English: Questions about medicines
Estonian: Ravimeid käsitlevad küsimused
English: Information on medicines authorised in individual Member States through national procedures can only be obtained through the national medicines regulatory authorities.
Estonian: Üksikutes liikmesriikides riikliku menetluse kaudu müügiloa saanud ravimite kohta saab teavet üksnes kohaliku riigi ravimiameti vahendusel.
English: Does the Agency have information on the availability of medicines in Member States?
Estonian: Kas ravimiametil on teavet ravimite kättesaadavuse kohta liikmesriikides?
English: Medicines regulatory authorities in Member States may be able to provide you with this information.
Estonian: Sellist teavet võivad teile anda liikmesriikide ravimiametid.
English: What acronym should I use for the Agency?
Estonian: Millist suurtähtlühendit peab ravimiameti kohta kasutama?
English: How can I get sales figures for a medicine?
Estonian: Kuidas saan teada ravimi müügiandmeid?
English: Does the Agency have any information on the price or reimbursement of medicines in Member States?
Estonian: Kas ravimiametil on teavet ravimite hindade ja hüvitiste kohta liikmesriikides?
English: They are not usually evaluated by medicines regulatory authorities, unless they contain a substance that has pharmacological activity or make a medicinal claim.
Estonian: Üldiselt ei hinda ravimiametid toidulisandeid, kui neis ei sisaldu farmakoloogilisi aineid või neil ei ole ravitoimet.
English: • food supplements;
Estonian: • toidulisanditega;
English: • homoeopathic medicines;
Estonian: • homöopaatiliste ravimitega;
English: In addition you may be eligible to take part in a clinical trial.
Estonian: Samuti võite liituda kliinilise uuringuga.
English: These are also published on EMA's homepage.
Estonian: Samuti avaldatakse need Euroopa Ravimiameti veebilehel.
English: How are food supplements evaluated?
Estonian: Kuidas hinnatakse toidulisandeid?
English: How can I search for a medicine on the Agency's website?
Estonian: Kuidas otsida ravimiameti veebilehel ravimi kohta teavet?
English: How are fees organised at the Agency?
Estonian: Kuidas on ravimiametis korraldatud teenustasude maksmine?
English: How are medical devices evaluated?
Estonian: Kuidas hinnatakse meditsiiniseadmeid?